Historique de carrière de Violetta Cotreau
Anciens postes connus de Violetta Cotreau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/12/2020 | 30/12/2022 |
| Corporate Officer/Principal | 30/12/2022 | 30/12/2022 | |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/12/2016 | 01/11/2020 |
Formation de Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Violetta Cotreau
- Expérience
